As of Oct 19
| -0.021 / -4.32%|
The 3 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 1.00, with a high estimate of 5.00 and a low estimate of 0.50. The median estimate represents a +115.05% increase from the last price of 0.47.
The current consensus among 3 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.